CompletedNot Applicable

Long-term Outcome After Heparin and Edoxaban Versus Heparin Plus Vit K Antagonists for Acute DVT and PE

France156 participantsStarted 2018-01-01

Plain-language summary

Centers that participated in the HOKUSAI VTE trial will be invited to collect follow of previously enrolled patients at least 2 years after the index VTE.

Who can participate

Age range18 Years – 99 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * patient who participated in the HOKUSAI VTE trial Exclusion Criteria: * patient deprived of liberty * patient under guardianship

What they're measuring

cumulative incidence of PTS in patients with an acute DVT

Timeframe: 2 years

PE related quality of life

Timeframe: 2 years after the index PE

Trial details

NCT IDNCT03757481

SponsorUniversity Hospital, Montpellier

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2020-03-03

View on ClinicalTrials.gov More Post Thrombotic Syndrome trials